Diagonal starts up with $128M to make better 'activator' antibody drugs
BioPharma
Stay updated with breaking news from Michael Gladstone. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pentwater Capital Management LP - Form 8.3 - Horizon Therapeutics Plc PR Newswire London, December 14 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH
Pentwater Capital Management LP - Form 8.3 - Horizon Therapeutics Plc PR Newswire London, December 13 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE
Pentwater Capital Management LP - Form 8.3 - HomeServe plc PR Newswire London, November 23 FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!